Results 361 to 370 of about 122,153 (397)

An update on PPAR activation by cannabinoids

open access: yesBritish Journal of Pharmacology, 2016
Saoirse E O'sullivan
exaly   +2 more sources
Some of the next articles are maybe not open access.

Related searches:

Cannabinoids

Current Drug Target -CNS & Neurological Disorders, 2005
Since the discovery of an endogenous cannabinoid system, research into the pharmacology and therapeutic potential of cannabinoids has steadily increased. Two subtypes of G-protein coupled cannabinoid receptors, CB(1) and CB(1), have been cloned and several putative endogenous ligands (endocannabinoids) have been detected during the past 15 years.
openaire   +2 more sources

Cannabinoids and the eye

Survey of Ophthalmology, 2021
Cannabis ranks among the most commonly used psychotropic drugs worldwide. In the context of the global movement toward more widespread legalisation, there is a growing need toward developing a better understanding of the physiological and pathological effects. We provide an overview of the current evidence on the effects of cannabinoids on the eye.
Michael T.M. Wang, Helen V. Danesh-Meyer
openaire   +2 more sources

Cannabinoids and Anxiety

2009
The term cannabinoids encompasses compounds produced by the plant Cannabis sativa, such as delta9-tetrahydrocannabinol, and synthetic counterparts. Their actions occur mainly through activation of cannabinoid type 1 (CB1) receptors. Arachidonoyl ethanolamide (anandamide) and 2-arachidonoyl glycerol (2-AG) serve as major endogenous ligands ...
Fabrício A, Moreira, Carsten T, Wotjak
openaire   +2 more sources

Cannabinoid analgesia

Pharmacology & Therapeutics, 2002
During the last decade, rigorous scientific methods have been applied to determine the effects of cannabinoids on nociceptive neurotransmission. Cannabinoids have been observed to markedly decrease signalling in specific neural pathways that transmit messages about pain.
J Michael, Walker, Susan M, Huang
openaire   +2 more sources

Cannabis, Cannabinoids, and Sleep: a Review of the Literature

Current Psychiatry Reports, 2017
Kimberly A Babson, Danielle M Morabito
exaly   +2 more sources

Synthetic Cannabinoids

The American Journal of the Medical Sciences, 2015
Synthetic cannabinoids (SCBs), also known under the brand names of "Spice," "K2," "herbal incense," "Cloud 9," "Mojo" and many others, are becoming a large public health concern due not only to their increasing use but also to their unpredictable toxicity and abuse potential.
Brooke, Mills   +2 more
openaire   +2 more sources

Positive and Negative Effects of Cannabis and Cannabinoids on Health

Clinical pharmacology and therapy, 2019
Cannabis is the most popular illicit drug in the Western world. Repeated cannabis use has been associated with short‐ and long‐term side effects, including respiratory and cardiovascular disorders, cognitive alterations, psychosis, schizophrenia, and ...
K. Cohen, Abraham Weizman, A. Weinstein
semanticscholar   +1 more source

Home - About - Disclaimer - Privacy